Analyst firms · Piper Sandler · OGN
Piper Sandler OGN price target and rating history
Organon & Co. (OGN) · Health Care
Piper Sandler rates Organon & Co. (OGN) Neutral with a $14 price target, as of its latest action on Apr 28, 2026. It has published 4 rating actions on OGN since October 2021, including 2 upgrades and 1 downgrade.
- Current rating
- Neutral
- Price target
- $14
- Median target, all firms
- Too few
- Actions on OGN
- 4
Piper Sandler price target on OGN
Every Piper Sandler rating on OGN
- Apr 28, 2026
- Oct 27, 2025
- Sep 6, 2022
- Oct 7, 2021
How other firms rate OGN
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Piper Sandler | Neutral | $14 | Apr 28, 2026 |
| Barclays | Underweight | $7.50 | Dec 9, 2025 |
Questions about Piper Sandler and OGN
- What is Piper Sandler's price target for OGN?
- Piper Sandler's latest stated price target for Organon & Co. (OGN) is $14, from its action on Apr 28, 2026.
- What is Piper Sandler's rating on OGN?
- Piper Sandler rates OGN Neutral, a neutral rating, as of Apr 28, 2026.
- When did Piper Sandler last change its view on OGN?
- On Apr 28, 2026, Piper Sandler upgrades to Neutral from Underweight, price target $14.
More OGN rating histories
All Piper Sandler ratingsOGN news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.